These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 19816013)

  • 21. Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction.
    Smak Gregoor PJ; van Gelder T; van Besouw NM; van der Mast BJ; IJzermans JN; Weimar W
    Transplantation; 2000 Jul; 70(1):143-8. PubMed ID: 10919591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60.
    Xenos EX; Ciancio G; Burke GW; Roth D; Miller J
    Clin Transplant; 1997 Oct; 11(5 Pt 2):497-9. PubMed ID: 9361949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer Screening of Renal Transplant Patients Undergoing Long-Term Immunosuppressive Therapy.
    Demir T; Ozel L; Gökçe AM; Ata P; Kara M; Eriş C; Özdemir E; Titiz MI
    Transplant Proc; 2015 Jun; 47(5):1413-7. PubMed ID: 26093731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A.
    Abou-Ayache R; Büchler M; Lepogamp P; Westeel PF; Le Meur Y; Etienne I; Lobbedez T; Toupance O; Caillard S; Goujon JM; Bergougnoux L; Touchard G
    Nephrol Dial Transplant; 2008 Jun; 23(6):2024-32. PubMed ID: 18199693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mycophenolate mofetil].
    Abramowicz D; Broeders N; Wissing M; Sternon J
    Rev Med Brux; 1998 Jun; 19(3):139-43. PubMed ID: 9697397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus-based regimens.
    Wlodarczyk Z; Walaszewski J; Perner F; Vitko S; Ostrowski M; Bachleda P; Kokot F; Klinger M; Szenohradszky P; Studenik P; Navratil P; Asztalos L; Rutkowski B; Kalmar KN; Hickey D
    Transpl Int; 2005 Feb; 18(2):157-62. PubMed ID: 15691267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy.
    Weir MR; Ward MT; Blahut SA; Klassen DK; Cangro CB; Bartlett ST; Fink JC
    Kidney Int; 2001 Apr; 59(4):1567-73. PubMed ID: 11260422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Introduction of mycophenolate mofetil and cyclosporine withdrawal in heart transplant patients with progressive deteriorating renal function.
    Dureau G; Obadia JF; Chuzel M; Boissonnat P
    Transplant Proc; 2000 Mar; 32(2):461-2. PubMed ID: 10715479
    [No Abstract]   [Full Text] [Related]  

  • 29. Pediatric renal transplantation with mycophenolate mofetil-based immunosuppression without induction: results after three years.
    Jungraithmayr T; Staskewitz A; Kirste G; Böswald M; Bulla M; Burghard R; Dippell J; Greiner C; Helmchen U; Klare B; Klaus G; Leichter HE; Mihatsch MJ; Michalk DV; Misselwitz J; Plank C; Querfeld U; Weber LT; Wiesel M; Tönshoff B; Zimmerhackl LB;
    Transplantation; 2003 Feb; 75(4):454-61. PubMed ID: 12605109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basiliximab and mycophenolate mofetil in combination with low-dose cyclosporine and methylprednisolone effectively prevent acute rejection in kidney transplant recipients.
    Kovac D; Kotnik V; Kandus A
    Transplant Proc; 2005 Dec; 37(10):4230-4. PubMed ID: 16387086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal transplantation in a case of acute intermittent porphyria.
    Warholm C; Wilczek H
    J Clin Pharmacol; 2003 Oct; 43(10):1158-60. PubMed ID: 14517198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful withdrawal of steroid after renal transplantation.
    Boletis JN; Konstadinidou I; Chelioti H; Theodoropoulou H; Avdikou K; Kostakis A; Stathakis CP
    Transplant Proc; 2001; 33(1-2):1231-3. PubMed ID: 11267272
    [No Abstract]   [Full Text] [Related]  

  • 33. CAPD--a risk factor in renal transplantation? ARF after transplantation.
    Lambert MC; Bernaert P; Vijt D; de Smet R; Lameire N
    Perit Dial Int; 1996; 16 Suppl 1():S495-8. PubMed ID: 8728255
    [No Abstract]   [Full Text] [Related]  

  • 34. Urinary mutagenic activity after different immunosuppressive protocols in renal transplant patients.
    Fracasso ME; Barba A; Tessari G; Gasperini S; Brunello F
    Mutat Res; 1993 Dec; 319(4):279-83. PubMed ID: 7504201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamic parameters of immunosuppressive drugs are not correlated with age, duration of dialysis, percentage of lymphocytes or lymphocyte stimulation index in renal transplant recipients.
    Sugiyama K; Isogai K; Toyama A; Satoh H; Saito K; Nakagawa Y; Tasaki M; Takahashi K; Saito N; Hirano T
    Biol Pharm Bull; 2008 Nov; 31(11):2146-9. PubMed ID: 18981589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term genotoxic effects of immunosuppressive drugs on lymphocytes of kidney transplant recipients.
    Lizotti Cilião H; Batista de Oliveira Camargo-Godoy R; Mazzaron Barcelos GR; Zanuto A; Daher Alvares Delfino V; de Syllos Cólus IM
    Mutat Res Genet Toxicol Environ Mutagen; 2016 Aug; 806():47-52. PubMed ID: 27476335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injury.
    De Greef KE; Ysebaert DK; Vercauteren SR; Chapelle T; Roeyen G; Bosmans JL; Verpooten GA; De Broe ME
    Transplant Proc; 2002 May; 34(3):791-4. PubMed ID: 12034184
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of ciclosporin on triglyceridemia in long-term renal transplant recipients.
    Verzola A; Bedani PL; Gilli P
    Nephron; 1999 Feb; 81(2):240-1. PubMed ID: 9933763
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of kidney or heart transplantation on the urinary excretion of epidermal growth factor.
    Amado JA; De-Francisco AL; Botana MA; Pesquera C; Vázquez-de-Prada JA; Arias M
    Transpl Int; 1994; 7(2):127-30. PubMed ID: 8179800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter: Arthralgia after high-dose steroids.
    Bennett WM; Strong D
    Lancet; 1975 Feb; 1(7902):332. PubMed ID: 46470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.